SCHEMBL6062976

SCHEMBL6062976

CS(=O)(=O)N=C(N[C@@H](CC1CCCCC1)C(=O)NCCCC(=O)c1nc2ccccc2o1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTSS P25774 10/20 0.46
CHRNB2 P17787 3/20 0.44
CHRNB4 P30926 3/20 0.44
CHRNA3 P32297 3/20 0.44
CHRNA4 P43681 3/20 0.44
CTSL P07711 3/20 0.43
CTSK P43235 2/20 0.43
CTSB P07858 1/20 0.43
MMP3 P08254 4/20 0.41
MMP1 P03956 3/20 0.41
MMP2 P08253 3/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRM1 Q13255 1/20 0.41
FAAH O00519 3/20 0.40
CES1 P23141 2/20 0.40
DAGLA Q9Y4D2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7259493 0.87 CTSS (0.45) CTSSCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL5946218 0.84 CTSS (0.52) CTSS
SCHEMBL5946225 0.84 CTSS (0.52) CTSS
SCHEMBL5946006 0.79 CTSS (0.39) CTSSCTSLCTSKCTSB
SCHEMBL5946001 0.79 CTSS (0.39) CTSSCTSLCTSKCTSB
SCHEMBL6635584 0.78 CTSS (0.51) CTSSCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL6062875 0.76 CTSS (0.53) CTSSCTSLCTSKCTSBMMP3
SCHEMBL6062871 0.76 CTSS (0.53) CTSSCTSLCTSKCTSBMMP3
SCHEMBL6061878 0.75 DAGLA (0.47) CTSSCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL5945992 0.75 CTSS (0.50) CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed